{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:46:22Z","timestamp":1792788382959,"version":"4.5.0"},"reference-count":36,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2025,5,31]],"date-time":"2025-05-31T00:00:00Z","timestamp":1748649600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2025,5,31]],"date-time":"2025-05-31T00:00:00Z","timestamp":1748649600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Therapeutic Advances in Chronic Disease"],"published-print":{"date-parts":[[2025,10]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Rosacea is a common inflammatory disease. Four clinical rosacea subtypes have been described, with the papulo-pustular being the most common. At present, the only FDA-approved treatment for papulo-pustular rosacea is low-dose doxycycline. Retinoids, in particular isotretinoin, have shown for decades positive outcomes in the treatment of rosacea, but due to the lack of robust evidence, they are still considered an off-label treatment for this condition.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives:<\/jats:title>\n                    <jats:p>Summarize the current evidence in the literature regarding the role of topical and systemic retinoids in the treatment of papulo-pustular rosacea.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design:<\/jats:title>\n                    <jats:p>Systematic review and meta-analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Data source and methods:<\/jats:title>\n                    <jats:p>A systematic MEDLINE, EMBASE, and Cochrane search of relevant publications on this topic was carried out. Randomized and non-randomized studies regarding topical and systemic retinoid treatment for rosacea were included. We excluded not relevant studies, case reports, reviews, and non-English language studies. We have used RoB2 and ROBINS-1 tool for assessing risk of bias in randomized and non-randomized trials, respectively.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Due to the heterogeneity in study design and outcomes reporting, the standardization of our results is limited, but the findings from this systematic review with meta-analysis indicate that retinoids, particularly isotretinoin, are a promising treatment option for papulopustular rosacea, with a favorable tolerability and safety profile. On the other hand, available data for topical retinoid therapy are less definitive and more contradictory, with only two randomized studies reporting opposite outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Retinoids may be a valid treatment option for rosacea, but larger, randomized controlled trials are needed to establish standardized dosing regimens and long-term safety profiles.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/20406223251339964","type":"journal-article","created":{"date-parts":[[2025,5,31]],"date-time":"2025-05-31T13:26:31Z","timestamp":1748697991000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":5,"title":["Rosacea and treatment with retinoids: a systematic review and meta-analysis"],"prefix":"10.1177","volume":"16","author":[{"given":"Alberto","family":"Sticchi","sequence":"first","affiliation":[{"name":"Department of Dermatology, University of Modena and Reggio Emilia, Modena, Italy"},{"name":"Azienda Unit\u00e0 Sanitaria Locale, IRCCS di Reggio Emilia, Skin Cancer Center, Reggio Emilia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flavio","family":"Fiorito","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University of Modena and Reggio Emilia, Modena, Italy"},{"name":"Azienda Unit\u00e0 Sanitaria Locale, IRCCS di Reggio Emilia, Skin Cancer Center, Reggio Emilia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaniko","family":"Kaleci","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University of Modena and Reggio Emilia, Modena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessia","family":"Paganelli","sequence":"additional","affiliation":[{"name":"Azienda Unit\u00e0 Sanitaria Locale, IRCCS di Reggio Emilia, Skin Cancer Center, Reggio Emilia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3601-655X","authenticated-orcid":false,"given":"Marco","family":"Manfredini","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University of Modena and Reggio Emilia, Modena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caterina","family":"Longo","sequence":"additional","affiliation":[{"name":"Azienda Unit\u00e0 Sanitaria Locale, IRCCS di Reggio Emilia, Skin Cancer Center, 42121, Reggio Emilia, Italy, University of Modena and Reggio Emilia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2025,5,31]]},"reference":[{"key":"e_1_3_4_2_2","doi-asserted-by":"publisher","DOI":"10.2147\/CCID.S126850"},{"key":"e_1_3_4_3_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40257-021-00595-7"},{"key":"e_1_3_4_4_2","doi-asserted-by":"publisher","DOI":"10.2165\/00128071-200203070-00005"},{"key":"e_1_3_4_5_2","unstructured":"Kang S Amagai M Bruckner AL et al. (eds). Fitzpatrick\u2019s dermatology 9e. McGraw-Hill Education https:\/\/Accessmedicine.Mhmedical.Com\/Content.Aspx?Bookid=2570&sectionid=210413309 (2019 accessed 17 April 2024)."},{"key":"e_1_3_4_6_2","doi-asserted-by":"publisher","DOI":"10.1080\/19381980.2017.1361574"},{"key":"e_1_3_4_7_2","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.13556"},{"issue":"2","key":"e_1_3_4_8_2","first-page":"282","article-title":"Incidence and prevalence of rosacea: a systematic review and meta-analysis","volume":"179","author":"Gether L","year":"2018","unstructured":"Gether L, Overgaard LK, Egeberg A, et al. Incidence and prevalence of rosacea: a systematic review and meta-analysis. Br J Dermatol 2018; 179(2): 282\u2013289.","journal-title":"Br J Dermatol"},{"key":"e_1_3_4_9_2","doi-asserted-by":"publisher","DOI":"10.1080\/09546634.2017.1309349"},{"key":"e_1_3_4_10_2","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2002.120625"},{"key":"e_1_3_4_11_2","doi-asserted-by":"publisher","DOI":"10.1021\/acs.molpharmaceut.3c00324"},{"key":"e_1_3_4_12_2","doi-asserted-by":"publisher","DOI":"10.1111\/ijd.14757"},{"key":"e_1_3_4_13_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40257-016-0185-5"},{"key":"e_1_3_4_14_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00403-020-02152-4"},{"issue":"4","key":"e_1_3_4_15_2","first-page":"22","article-title":"Updated physician\u2019s guide to the off-label uses of oral isotretinoin","volume":"7","author":"Nickle SB","year":"2014","unstructured":"Nickle SB, Peterson N, Peterson M. Updated physician\u2019s guide to the off-label uses of oral isotretinoin. J Clin Aesthet Dermatol 2014; 7(4): 22\u201334.","journal-title":"J Clin Aesthet Dermatol"},{"key":"e_1_3_4_16_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4632.2004.02130.x"},{"issue":"3","key":"e_1_3_4_17_2","first-page":"333","article-title":"A randomized, double-blind, placebo-controlled, pilot study to assess the efficacy and safety of clindamycin 1.2% and tretinoin 0.025% combination gel for the treatment of acne rosacea over 12 weeks","volume":"11","author":"Chang ALS","year":"2012","unstructured":"Chang ALS, Alora-Palli M, Lima XT, et al. A randomized, double-blind, placebo-controlled, pilot study to assess the efficacy and safety of clindamycin 1.2% and tretinoin 0.025% combination gel for the treatment of acne rosacea over 12 weeks. J Drugs Dermatol 2012; 11(3): 333\u2013339.","journal-title":"J Drugs Dermatol"},{"key":"e_1_3_4_18_2","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.14349"},{"key":"e_1_3_4_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2014.08.027"},{"key":"e_1_3_4_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijsu.2021.105906"},{"key":"e_1_3_4_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/0197-2456(86)90046-2"},{"key":"e_1_3_4_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2016.01.025"},{"issue":"7","key":"e_1_3_4_23_2","first-page":"505","article-title":"Systemic isotretinoin in the treatment of rosacea\u2014doxycycline- and placebo-controlled, randomized clinical study","volume":"8","author":"Gollnick H","year":"2010","unstructured":"Gollnick H, Blume-Peytavi U, Szab\u00f3 EL, et al. Systemic isotretinoin in the treatment of rosacea\u2014doxycycline- and placebo-controlled, randomized clinical study. J Dtsch Dermatol Ges 2010; 8(7): 505\u2013514.","journal-title":"J Dtsch Dermatol Ges"},{"key":"e_1_3_4_24_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4362.1986.tb04533.x"},{"key":"e_1_3_4_25_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.1994.01690030051008"},{"key":"e_1_3_4_26_2","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-1204"},{"key":"e_1_3_4_27_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.134.7.884"},{"key":"e_1_3_4_28_2","doi-asserted-by":"publisher","DOI":"10.1111\/jocd.12982"},{"key":"e_1_3_4_29_2","doi-asserted-by":"publisher","DOI":"10.2340\/00015555678991"},{"key":"e_1_3_4_30_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2230.2004.01472.x"},{"key":"e_1_3_4_31_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2230.1984.tb00842.x"},{"key":"e_1_3_4_32_2","doi-asserted-by":"publisher","DOI":"10.1111\/dth.14986"},{"key":"e_1_3_4_33_2","doi-asserted-by":"publisher","DOI":"10.1111\/ajd.12522"},{"key":"e_1_3_4_34_2","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-0888"},{"issue":"12","key":"e_1_3_4_35_2","first-page":"1410","article-title":"Clindamycin phosphate 1.2% and tretinoin 0.025% gel for rosacea: summary of a placebo-controlled, double-blind trial","volume":"11","author":"Freeman SA","year":"2012","unstructured":"Freeman SA, Moon SD, Spencer JM. Clindamycin phosphate 1.2% and tretinoin 0.025% gel for rosacea: summary of a placebo-controlled, double-blind trial. J Drugs Dermatol 2012; 11(12): 1410\u20131414.","journal-title":"J Drugs Dermatol"},{"key":"e_1_3_4_36_2","doi-asserted-by":"publisher","DOI":"10.1159\/000051380"},{"key":"e_1_3_4_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2023.12.017"}],"container-title":["Therapeutic Advances in Chronic Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/20406223251339964","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/20406223251339964","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/20406223251339964","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T23:20:10Z","timestamp":1777591210000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/20406223251339964"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,31]]},"references-count":36,"alternative-id":["10.1177\/20406223251339964"],"URL":"https:\/\/doi.org\/10.1177\/20406223251339964","relation":{},"ISSN":["2040-6223","2040-6231"],"issn-type":[{"value":"2040-6223","type":"print"},{"value":"2040-6231","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,31]]},"article-number":"20406223251339964"}}